Extracorporeal membrane oxygenation support for SARS-CoV-2: a multi-centered, prospective, observational study in critically ill 92 patients in Saudi Arabia.
Saad AlhumaidAbbas Al MutairHeader A AlghazalAli J AlhaddadHassan Al-HelalSadiq A Al SalmanJalal AlaliSana AlmahmoudZulfa M AlhejyAhmad A AlbagshiJaved MuhammadAmjad KhanTarek SulaimanMaha Al-MozainiKuldeep DhamaJaffar A Al-TawfiqAli A RabaanPublished in: European journal of medical research (2021)
Following the use of ECMO, the mortality rate of patients and length of ICU and hospital stay were not improved. However, these findings need to be carefully interpreted, as most of our cohort patients were relatively old and had multiple severe comorbidities. Future randomized trials, although challenging to conduct, are highly needed to confirm or dispute reported observations.
Keyphrases
- extracorporeal membrane oxygenation
- end stage renal disease
- sars cov
- chronic kidney disease
- acute respiratory distress syndrome
- newly diagnosed
- prognostic factors
- peritoneal dialysis
- healthcare
- intensive care unit
- cardiovascular disease
- mechanical ventilation
- coronary artery disease
- coronavirus disease
- early onset
- current status